peptide

TB-500 (Thymosin Beta-4): Research Overview

September 18, 2026 · By My Store 3 Admin

TB-500 is a synthetic analogue of Thymosin Beta-4 (TB-4), a naturally occurring 43-amino acid peptide present in virtually all human and animal cells. It is one of the most studied members of the beta-thymosin family, with preclinical research focused primarily on its role in tissue repair, cellular migration, and inflammatory modulation.

This article provides a research-focused overview of TB-500, its molecular basis, proposed mechanisms, and current scientific status. All Bloom Vitality products are supplied strictly for in vitro laboratory and research use only.

Molecular Profile

Thymosin Beta-4 is encoded by the TMSB4X gene and is found at high concentrations in platelets, wound fluid, and various tissue types. The active research fragment most commonly associated with TB-500 corresponds to the actin-binding domain of TB-4: the tetrapeptide sequence Ac-LKKTETQ. TB-500 as supplied for research purposes is typically a 17-amino acid fragment of the full TB-4 sequence, selected for its proposed bioactivity and stability.

Proposed Mechanisms

Actin sequestration — TB-4 binds G-actin (monomeric actin), regulating its polymerisation. This is thought to influence cell migration and wound healing responses.
Angiogenesis — Preclinical studies suggest TB-4 promotes blood vessel formation, potentially via upregulation of VEGF and related pathways.
Anti-inflammatory activity — Research indicates TB-4 may downregulate inflammatory cytokines including NF-κB, potentially reducing inflammatory signalling in damaged tissue.
Stem cell differentiation — Some studies suggest TB-4 may promote differentiation of progenitor cells relevant to cardiac and skeletal muscle repair.

Areas of Preclinical Research

Tendon and ligament healing
Skeletal muscle repair following injury
Cardiac tissue protection and repair
Wound healing and skin repair
Neurological recovery models
Ocular surface repair

TB-500 vs TB-4: Key Distinction

TB-500 refers to the synthetic research peptide commonly used in laboratory settings. Full-length Thymosin Beta-4 (TB-4) is the naturally occurring endogenous protein. Bloom Vitality supplies both TB-500 and TB-500 (TB-4) 10mg as separate research materials for investigators requiring either form.

Research Status

TB-500 and TB-4 remain at the preclinical stage for most investigated applications. Some Thymosin Beta-4 derivatives have entered early-phase clinical investigation for specific indications (notably dry eye and cardiac conditions), but these are distinct programmes from the synthetic research peptide commonly referred to as TB-500. No form is approved as a therapeutic agent in the UK.

TB-500 Research Material

Bloom Vitality supplies TB-500 10mg and TB-500 (TB-4) 10mg as lyophilised research vials, independently third-party tested for purity and potency. Batch-specific Certificates of Analysis are available via our Certificates & Documentation page, and our testing methodology is detailed on the Testing & Quality page.

Researchers investigating combined protocols may also be interested in our BPC-157 + TB-500 Blend.